The ongoing Phase 3 clinical programme (TRIUMPH) is evaluating retatrutide's efficacy and safety in larger, more diverse populations, including people with type 2 diabetes and obesity-related complications
publication, authors of the study are from Australia) Stanford Press Release: JAMA article: Dixit AA, Bateman BT, Hawn MT, Odden MC, Sun EC
+ Currently, our IV therapy is administered at our BHRC West Los Angeles location where you have full medical oversight and access to a comfortable infusion suite
As cells divide, telomeres shorten
That's why we offer a FAST TRACK option for those who want to start compounded versions of GLP1 medications (Semaglutide or Tirzepatide) but need an affordable, out of pocket cost option